Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziyin-Xiehuo Herbs and Acupuncture for Idiopathic Precocious Puberty
NCT06510764Phase 3Recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Sep 2024
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Idiopathic precocious puberty (CPP) (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoint: Percentage of subjects' mammary nucleus minification or disappearance at 3 months. Started Sep 2024; status: recruiting.
02
Conditions
Idiopathic precocious puberty (CPP)
Beyond the preview
Go deeper on NCT06510764.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06510764.